FDA Expands Atogepant Approval to Include Chronic Migraine ...Middle East

Medscape - News
The oral CGRP receptor antagonist atogepant is now approved to prevent migraine across frequencies, including episodic and chronic migraine. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Expands Atogepant Approval to Include Chronic Migraine )

Also on site :